U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801626) titled 'Novel Strategies for Reducing Burn Scar Itch' on Jan. 24.
Brief Summary: The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Burn Scar
Itch Scarring
Wound
Intervention:
COMBINATION_PRODUCT: Famotidine and 4% topical cromolyn sodium
Patients will be instructed to take a 20mg famotidine capsule twice daily, and to use the lotion (4% cromolyn sodium) twice daily.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: The University of Texas Medical Branch, Galveston
Publis...